Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04714424 · ClinicalTrials.gov registry record
Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 84
- Enrollment target
NCT04714424: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT04714424 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04714424 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the results of vision tests that are algorithmically derived and delivered through a virtual reality headset with those delivered through the existing technology standards (eg. Humphrey for field tests). Tests that the researchers will be conducting include vision field perimetry, Amsler, acuity chart, contrast- sensitivity and currently used office tests.
Primary Outcome
Vision field perimetry will me measured using Humphrey Vision Field Analyzer and a VR equivalent software.
Interventions
- DEVICE Virtual Reality Headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2022-10-24 |
What the finished NCT04714424 record still lists
NCT04714424 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Headset is the first listed.
NCT04714424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04714424 about?
NCT04714424 is a clinical study titled "Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues". The purpose of this study is to compare the results of vision tests that are algorithmically derived and delivered through a virtual reality headset with those delivered through the existing technology standards (eg. Humphrey for field tests). Tests that the researchers will be conducting include vi...
What is the current status of trial NCT04714424?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2020-01-13. Estimated completion is 2022-10-24.
What interventions are being tested in trial NCT04714424?
The interventions under investigation include: Virtual Reality Headset (DEVICE).
Who is sponsoring clinical trial NCT04714424?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI